Seeking Alpha04/11/2026 02:09:27

Dr. Reddy's granted FDA nod for first generic targeting Gilead’s Yeztugo

Dr. Reddy's granted FDA nod for first generic targeting Gilead’s Yeztugo

1 hour ago
View Original Source
Seeking Alpha

Seeking Alpha

Seeking Alpha is the leading platform for investors to research and discuss US-traded stocks and ETFs. Our platform helps investors to find successful investing ideas and to successfully manage their portfolios. It provides investment ideas, analysis, news, ratings, investing tools and community discussion.

More from Seeking Alpha

Fortis outlines $32.2B 5-year capital plan with 7.5% rate base CAGR and extends 4%-6% dividend growth through 2031

6 min ago

Alstom sinks as J.P. Morgan and CIti downgrade on prolonged margin pressure

6 min ago

SK Hynix in spotlight as Commerce Dept. holds up Chinese equipment plans: report

8 min ago

Sotera Health reaffirms 2026 outlook, targets adjusted EPS of $0.95 to $1.01 amid European med device softness

9 min ago